JP2012508865A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508865A5 JP2012508865A5 JP2011535211A JP2011535211A JP2012508865A5 JP 2012508865 A5 JP2012508865 A5 JP 2012508865A5 JP 2011535211 A JP2011535211 A JP 2011535211A JP 2011535211 A JP2011535211 A JP 2011535211A JP 2012508865 A5 JP2012508865 A5 JP 2012508865A5
- Authority
- JP
- Japan
- Prior art keywords
- antigens
- listed
- pattern
- group
- reactivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 82
- 102000036639 antigens Human genes 0.000 claims 82
- 108091007433 antigens Proteins 0.000 claims 82
- 230000009257 reactivity Effects 0.000 claims 18
- 239000000523 sample Substances 0.000 claims 17
- 238000000034 method Methods 0.000 claims 16
- 201000006417 multiple sclerosis Diseases 0.000 claims 14
- 208000007118 chronic progressive multiple sclerosis Diseases 0.000 claims 13
- 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 claims 9
- 230000003902 lesion Effects 0.000 claims 8
- 201000008628 secondary progressive multiple sclerosis Diseases 0.000 claims 7
- 206010063401 primary progressive multiple sclerosis Diseases 0.000 claims 6
- 230000001575 pathological effect Effects 0.000 claims 2
- 238000003909 pattern recognition Methods 0.000 claims 2
- 239000013068 control sample Substances 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11364508P | 2008-11-12 | 2008-11-12 | |
| US61/113,645 | 2008-11-12 | ||
| PCT/IL2009/001066 WO2010055510A2 (en) | 2008-11-12 | 2009-11-12 | Diagnosis of multiple sclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508865A JP2012508865A (ja) | 2012-04-12 |
| JP2012508865A5 true JP2012508865A5 (cg-RX-API-DMAC7.html) | 2012-12-27 |
Family
ID=42170484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535211A Pending JP2012508865A (ja) | 2008-11-12 | 2009-11-12 | 多発性硬化症の診断 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9267945B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2353004B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012508865A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102388307B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009315230A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2743590A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010055510A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140105980A1 (en) | 2012-10-11 | 2014-04-17 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| US20190263888A1 (en) | 2010-10-19 | 2019-08-29 | Op-T Llc | Therapeutic peptides and methods for treating autoimmune related disease |
| EP3421487B1 (en) | 2010-10-19 | 2023-06-28 | The Regents of the University of Colorado, a body corporate | Peptides for modulating t-cell activity and uses thereof |
| US9511151B2 (en) | 2010-11-12 | 2016-12-06 | Uti Limited Partnership | Compositions and methods for the prevention and treatment of cancer |
| US10988516B2 (en) | 2012-03-26 | 2021-04-27 | Uti Limited Partnership | Methods and compositions for treating inflammation |
| US8652999B1 (en) | 2012-07-24 | 2014-02-18 | Dow Agrosciences, Llc. | Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone |
| US9603948B2 (en) | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
| CN105899229A (zh) | 2013-11-04 | 2016-08-24 | Uti有限合伙公司 | 用于持续的免疫治疗的方法和组合物 |
| CA2933554A1 (en) * | 2013-12-12 | 2015-06-18 | The Brigham And Women's Hospital, Inc. | Treating neurodegenerative disease |
| WO2015101988A1 (en) | 2013-12-31 | 2015-07-09 | Yeda Research And Development Co. Ltd. | Diagnosis of systemic lupus erythematosus using oligonucleotides antigens |
| EP3090263A4 (en) | 2013-12-31 | 2017-08-23 | Yeda Research and Development Co., Ltd. | Methods for assaying immunological competence |
| WO2015148389A2 (en) * | 2014-03-23 | 2015-10-01 | The Regents Of The University Of Colorado | Diagnosis of multiple sclerosis in human and animal subjects |
| EP2927687A1 (en) * | 2014-03-31 | 2015-10-07 | Ecole Polytechnique Federale de Lausanne (EPFL) | Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods |
| WO2015172008A1 (en) * | 2014-05-09 | 2015-11-12 | Multiple Sclerosis Research Center Of New York | Transglutaminadase 6 as a biomarker for multiple sclerosis |
| WO2016123565A1 (en) | 2015-01-30 | 2016-08-04 | The Regents Of The University Of California | N-acetyl glucosamine as a biomarker of ms disease course |
| WO2016139659A1 (en) | 2015-03-01 | 2016-09-09 | Immunarray Ltd. | Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens |
| WO2016198932A2 (en) | 2015-05-06 | 2016-12-15 | Uti Limited Partnership | Nanoparticle compositions for sustained therapy |
| CN107043413A (zh) * | 2016-02-05 | 2017-08-15 | 华中农业大学 | 一种肺结核相关的尿液生物标志蛋白及其应用 |
| WO2018048884A1 (en) * | 2016-09-09 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating autoimmune gfap astrocytopathy |
| DK3538559T3 (da) | 2016-11-09 | 2025-07-14 | Uti Lp | Rekombinante pmhc klasse ii-molekyler |
| AU2018248961B2 (en) | 2017-04-07 | 2024-06-20 | Uti Limited Partnership | Assay to measure the potency of receptor-ligand interactions in nanomedicines |
| CN111741746A (zh) | 2017-11-29 | 2020-10-02 | 乌第有限合伙公司 | 治疗自身免疫性疾病的方法 |
| US11793854B2 (en) | 2019-03-21 | 2023-10-24 | Op-T Llc | Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction |
| US12048734B2 (en) | 2020-04-17 | 2024-07-30 | Op-T Llc | Bioactive peptides and methods of use thereof |
| CN114689865A (zh) * | 2020-12-30 | 2022-07-01 | 广州市微米生物科技有限公司 | 视神经脊髓炎抗体检测试剂 |
| CN113336862B (zh) * | 2021-07-05 | 2022-03-01 | 广东省科学院动物研究所 | 一种抗多发性硬化的重组蛋白及其制备方法和用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL137460A0 (en) | 2000-07-24 | 2001-07-24 | Yeda Res & Dev | Identifying antigen clusters for monitoring a global state of an immune system |
| EP1351707B9 (en) * | 2001-01-09 | 2012-01-25 | Baylor Research Institute | Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| EP1386155A4 (en) | 2001-04-10 | 2006-05-10 | Univ Leland Stanford Junior | THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES |
| US20030092089A1 (en) | 2001-11-14 | 2003-05-15 | Moscarello Mario Anthony | Method for diagnosing multiple sclerosis and an assay therefore |
| IL148401A0 (en) | 2002-02-26 | 2002-09-12 | Hadasit Med Res Service | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases |
| US20050009096A1 (en) | 2002-10-11 | 2005-01-13 | The Regents Of The University Of California | Method for diagnosis and prognosis of multiple sclerosis |
| US20050260770A1 (en) | 2004-04-01 | 2005-11-24 | Cohen Irun R | Antigen array and diagnostic uses thereof |
| EA200700263A1 (ru) | 2004-07-01 | 2007-06-29 | Кебенхавнс Университет | Способ лечения и профилактики рассеянного склероза путём лечения лептоспирозной инфекции |
| US20080194711A1 (en) * | 2005-01-19 | 2008-08-14 | Frauke Zipp-Nitsch | Cx3Cr1 As A Marker Which Correlates With Both Disease And Disease Activity In Multiple Sclerosis Patients |
| US7572592B2 (en) | 2005-01-31 | 2009-08-11 | Glycominds Ltd | Method for diagnosing multiple sclerosis |
| JP2008532936A (ja) | 2005-02-14 | 2008-08-21 | ワイス | インターロイキン−１７ｆ抗体及び他のｉｌ−１７ｆシグナル伝達拮抗物質並びにそれらの使用 |
| WO2006116155A2 (en) * | 2005-04-21 | 2006-11-02 | The Regents Of The University Of California | A method for diagnosis and prognosis of multiple sclerosis subtypes |
| WO2007014001A2 (en) * | 2005-07-21 | 2007-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Multiplex determination of lipid specific binding moieties |
| WO2007056332A2 (en) * | 2005-11-07 | 2007-05-18 | Vanderbilt University | Molecular diagnosis of autoimmune diseases |
| AU2007266218C1 (en) | 2006-05-26 | 2013-05-23 | Phenomenome Discoveries Inc. | Biomarkers for diagnosing multiple sclerosis, and methods thereof |
| CN101680883A (zh) * | 2007-04-12 | 2010-03-24 | 艾匹托普国际股份有限公司 | 用于多发性硬化的生物标记 |
-
2009
- 2009-11-12 US US13/128,862 patent/US9267945B2/en not_active Expired - Fee Related
- 2009-11-12 CA CA2743590A patent/CA2743590A1/en not_active Abandoned
- 2009-11-12 EP EP09825840.3A patent/EP2353004B1/en not_active Not-in-force
- 2009-11-12 AU AU2009315230A patent/AU2009315230A1/en not_active Abandoned
- 2009-11-12 JP JP2011535211A patent/JP2012508865A/ja active Pending
- 2009-11-12 WO PCT/IL2009/001066 patent/WO2010055510A2/en not_active Ceased
- 2009-11-12 CN CN200980154256.5A patent/CN102388307B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012508865A5 (cg-RX-API-DMAC7.html) | ||
| CN109142755B (zh) | 一种诊断早期食管鳞状细胞癌的四种自身抗体联合检测试剂盒及应用 | |
| JP2008532014A5 (cg-RX-API-DMAC7.html) | ||
| CN109661578A (zh) | 用于区分细菌和病毒感染的蛋白质特征 | |
| JP2013532295A5 (cg-RX-API-DMAC7.html) | ||
| JP2009522578A5 (cg-RX-API-DMAC7.html) | ||
| JP2012502281A5 (cg-RX-API-DMAC7.html) | ||
| MX2014014275A (es) | Genes nano46 y metodos para predecir el resultado del cancer de mama. | |
| JP2011506917A5 (cg-RX-API-DMAC7.html) | ||
| JP2014512511A (ja) | 肺がん試験 | |
| CN108490178A (zh) | 用于npc诊断及预后预测的标志物及其应用 | |
| JP2012531581A5 (cg-RX-API-DMAC7.html) | ||
| JP2016519767A5 (cg-RX-API-DMAC7.html) | ||
| CN108548923B (zh) | 肺小细胞癌早期特异性自身抗体panel诊断试剂盒 | |
| CN111579786B (zh) | 一种用于高危人群早期食管鳞癌筛查的试纸条 | |
| CN107255711B (zh) | 骨桥蛋白用于制备或筛选慢加急性肝衰竭诊断试剂的用途 | |
| JP2006508326A5 (cg-RX-API-DMAC7.html) | ||
| CN109735619A (zh) | 与非小细胞肺癌预后相关的分子标志物及其应用 | |
| CN112481380B (zh) | 一种评估晚期膀胱癌抗肿瘤免疫治疗反应性和预后生存的标志物及其应用 | |
| CN104975082A (zh) | 一组用于评估肺癌预后的基因及其应用 | |
| CN109085355A (zh) | 血清蛋白标志物组合在肺癌筛查和诊治中的应用 | |
| Xu et al. | Zwitterionic mesoporous engineering aids peptide-dependent pattern profiling for identification of different liver diseases | |
| CN108802400B (zh) | 一种检测复合物IgA1-α1MG的方法及无创检测肾组织损伤的试剂盒 | |
| Lalosevic et al. | Clinical scores for the prediction of esophageal varices in patients with liver cirrhosis | |
| CN108362884B (zh) | 一种肿瘤危险度和治疗效果评估的血清及组织分子指标 |